Skip to main content
. Author manuscript; available in PMC: 2018 Dec 28.
Published in final edited form as: Life Sci. 2018 Jan 31;196:118–126. doi: 10.1016/j.lfs.2018.01.021

Fig. 4.

Fig. 4.

Expression of key proteins in non-failing RV and PAH-mediated RV failure.

Relative protein expression (normalized to GAPDH) in non-failing (control) RV samples and PAH-mediated RV failure samples; note significant increase (*) in expression of FBN2, FIGF, and CTGF in PAH-mediated RV failure samples. Representative (single sample) immunoblots of each protein in control non-failing RV and PAH-mediated RV failure tissue in Supplementary Fig. 1.